| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Department of Basic Medical Science, School of Medicine and Shock/Trauma Research Center, University of Missouri, Kansas City, MO 64108;
Department of Animal Health and Biomedical Sciences, University of Wisconsin, Madison, WI 53706;
Department of Microbiology and Immunology, University of Maryland, Baltimore, MD 21201; and
Department of Surgical Science, University of Missouri, Kansas City, MO 64108
We have developed a novel LPS probe using a highly purified and homogenous preparation of [3H] Escherichia coli LPS from the deep rough mutant, which contains a covalently linked, photoactivable 4-p-(azidosalicylamido)-butylamine group. This cross-linker was used to identify the LPS-binding proteins in membranes of the murine-macrophage-like cell line RAW 264.7. The 
-subunit (PSMA1 C2, 29.5 kDa) and the 
-subunit (PSMB4 N3, 24.36 kDa) of the 20S proteasome complex were identified as LPS-binding proteins. This is the first report demonstrating LPS binding to enzymes such as the proteasome subunits. Functionally, LPS enhanced the chymotrypsin-like activity of the proteasome to degrade synthetic peptides in vitro and, conversely, the proteasome inhibitor lactacystin completely blocked the LPS-induced proteasome’s chymotrypsin activity as well as macrophage TNF- secretion and the expression of multiple inflammatory mediator genes. Lactacystin also completely blocked the LPS-induced expression of Toll-like receptor 2 mRNA. In addition, lactacystin dysregulated mitogen-activated protein kinase phosphorylation in LPS-stimulated macrophages, but failed to inhibit IL-1 receptor-associated kinase-1 activity. Importantly, lactacystin also prevented LPS-induced shock in mice. These data strongly suggest that the proteasome complex regulates the LPS-induced signal transduction and that it may be an important therapeutic target in Gram-negative sepsis.
This article has been cited by other articles:
|
|
 |
|
  S. Dhungana, B. A. Merrick, K. B. Tomer, and M. B. Fessler Quantitative Proteomics Analysis of Macrophage Rafts Reveals Compartmentalized Activation of the Proteasome and of Proteasome-mediated ERK Activation in Response to Lipopolysaccharide Mol. Cell. Proteomics, January 1, 2009; 8(1): 201 - 213. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Reis, Xiaoyu Tan, Rongjie Yang, C. E. Rockwell, C. J. Papasian, S. N. Vogel, D. C. Morrison, A. A. Qureshi, and N. Qureshi A combination of proteasome inhibitors and antibiotics prevents lethality in a septic shock model Innate Immunity, October 1, 2008; 14(5): 319 - 329. [Abstract] [PDF]
|
|
|
|
 |
|
 A. G. Atanasov, I. D. Ignatova, L. G. Nashev, B. Dick, P. Ferrari, F. J. Frey, and A. Odermatt Impaired Protein Stability of 11beta-Hydroxysteroid Dehydrogenase Type 2: A Novel Mechanism of Apparent Mineralocorticoid Excess J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1262 - 1270. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kobayashi, S.-i. Saitoh, N. Tanimura, K. Takahashi, K. Kawasaki, M. Nishijima, Y. Fujimoto, K. Fukase, S. Akashi-Takamura, and K. Miyake Regulatory Roles for MD-2 and TLR4 in Ligand-Induced Receptor Clustering J. Immunol., May 15, 2006; 176(10): 6211 - 6218. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. Lei, X. Tan, N. Qureshi, and D. C. Morrison Regulation of Cellular Caveolin-1 Protein Expression in Murine Macrophages by Microbial Products Infect. Immun., December 1, 2005; 73(12): 8136 - 8143. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Silverstein Review: D-Galactosamine lethality model: scope and limitations Innate Immunity, June 1, 2004; 10(3): 147 - 162. [Abstract] [PDF]
|
|
|
|
|
|
N. McCartney-Francis, W. Jin, and S. M. Wahl Aberrant Toll Receptor Expression and Endotoxin Hypersensitivity in Mice Lacking a Functional TGF-{beta}1 Signaling Pathway J. Immunol., March 15, 2004; 172(6): 3814 - 3821. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
